Skip to content

US · BTSG · MEDICAL - HEALTHCARE INFORMATION SERVICES

BrightSpring Health Services, Inc. Common Stock (BTSG) intrinsic value and stock valuation

$62.89as of 2026-11-21 · Mkt cap 12.37B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

BrightSpring Health Services, Inc. Common Stock DCF and intrinsic value

InvestorsCraft values BTSG with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from BTSG’s statements →

BrightSpring Health Services, Inc. Common Stock Graham Number

Graham Number: $14.04d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Louisville, KY 40222 brightspringhealth.com

How the business is doing

Fiscal 2018–2025, USD

Revenue
$12.9B+18.3% 5y CAGRd
20182025
Net income
$190.7M+55.7% 5y CAGRd
20182025
Free cash flow
$394.7M+18.2% 5y CAGRd
20182025
Total equity
$1.89B+20.7% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$12.9B$11.3B$8.83B$7.72B$6.7B
Operating income$295.3M$206.4M$147.2M$187.8M$234.2M
Net income$190.7M-$-18.06M-$-154.6M-$-53.91M$49.8M
EPSd$867.6K-$-93.58K-$-903.09K-$-314.91K$290.9K
Operating cash flow$490.2M$23.8M$210.8M-$-4.65M$270.2M
Capital expenditure-$-95.48M-$-80.91M-$-73.53M-$-70.11M-$-59.27M
Free cash flow$394.7M-$-57.14M$137.3M-$-74.77M$210.9M
Total assets$6.41B$5.93B$5.53B$5.44B$5.51B
Total debt$2.71B$2.9B$3.67B$3.68B$3.77B
Net debt$2.62B$2.84B$3.66B$3.66B$3.72B
Total equity$1.89B$1.65B$612.6M$784.1M$800.5M
Cash and short-term investments$88.4M$61.3M$13.1M$13.6M$46.7M
Income statement
20252024202320222021
Revenue$12.9B$11.3B$8.83B$7.72B$6.7B
Cost of revenue$11.4B$9.68B$7.39B$6.37B$5.45B
Gross profit$1.52B$1.59B$1.43B$1.35B$1.25B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$1.22B$1.38B$1.29B$1.13B$1.01B
Other expenses$0.00$0.00$0.00$40.9M$0.00
Operating expenses$1.22B$1.38B$1.29B$1.17B$1.01B
Cost and expenses$12.6B$11.1B$8.68B$7.53B$6.46B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$157.3M$228.4M$324.6M$233.6M$165.3M
Depreciation and amortization$164.3M$204.5M$202.3M$204M$199.2M
Ebitda$459.5M$398.1M$349.5M$391.8M$433.3M
Operating income$295.3M$206.4M$147.2M$187.8M$234.2M
Total other income/expenses, net-$-157.31M-$-241.11M-$-324.59M-$-233.58M-$-165.32M
Income before tax$137.9M-$-34.74M-$-177.41M-$-45.75M$68.9M
Income tax expense$33.2M-$-14.22M-$-20.58M$8.46M$17.6M
Net income$190.7M-$-18.06M-$-154.6M-$-53.91M$49.8M
Weighted average shares outstanding$202.6M$193M$171.2M$171.2M$171.2M
Weighted average diluted shares outstanding$219.8M$193M$171.2M$171.2M$171.2M
Balance sheet
20252024202320222021
Cash and short-term investments$88.4M$61.3M$13.1M$13.6M$46.7M
Net receivables$1.07B$1.15B$1.01B$868.4M$805M
Inventory$815.2M$640.6M$402.8M$430.5M$299.2M
Total current assets$2.89B$1.89B$1.46B$1.34B$1.18B
Property, plant and equipment, net$376.3M$500M$513.4M$475.3M$524.6M
Goodwill and intangible assets$3.1B$3.48B$3.49B$3.55B$3.77B
Long-term investments$8.2M$670K$720K$740K$2.66M
Total non-current assets$3.52B$4.03B$4.08B$4.1B$4.33B
Total assets$6.41B$5.93B$5.53B$5.44B$5.51B
Accounts payable$1.22B$941.3M$641.6M$526.9M$408.1M
Short-term debt$102.1M$130.5M$114.5M$107.9M$125.2M
Deferred revenue$9.04M$11M$30.9M$29M$10.5M
Total current liabilities$1.85B$1.43B$1.25B$932.5M$892.2M
Long-term debt$2.61B$2.77B$3.56B$3.57B$3.65B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$2.68B$2.85B$3.67B$3.72B$3.82B
Capital lease obligations$199.7M$294.4M$306.4M$282.4M$336.8M
Total liabilities$4.53B$4.27B$4.92B$4.66B$4.71B
Common stock$1.92M$1.74M$1.18M$1.18M$1.18M
Retained earnings-$-74.65M-$-222.16M-$-200.32M-$-45.72M$970K
Accumulated other comprehensive income (loss)-$-6.69M$1.42M$12.5M$21.2M$220K
Total equity$1.89B$1.65B$612.6M$784.1M$800.5M
Total investments$8.2M$670K$720K$740K$2.66M
Total debt$2.71B$2.9B$3.67B$3.68B$3.77B
Net debt$2.62B$2.84B$3.66B$3.66B$3.72B
Cash flow statement
20252024202320222021
Net income$189.1M-$-20.52M-$-156.84M-$-54.22M$51.3M
Depreciation and amortization$164.3M$204.5M$202.3M$204M$199.2M
Stock-based compensation$70.1M$69.2M$3.92M$3.55M$4.52M
Change in working capital-$-18.54M-$-270.07M$159.4M-$-224.47M-$-30.11M
Accounts receivable-$-131.29M-$-179.04M-$-127.25M-$-150.47M-$-93M
Inventory-$-177.91M-$-236.51M$28.7M-$-131.83M$4.29M
Accounts payable$264.2M$303.2M$105.7M$133.5M$63.5M
Net cash provided by operating activities$490.2M$23.8M$210.8M-$-4.65M$270.2M
Investments in property, plant and equipment-$-95.48M-$-80.91M-$-73.53M-$-70.11M-$-59.27M
Acquisitions, net-$-204.56M-$-59.8M-$-63.06M$113.3M-$-1.13B
Net cash used for investing activities-$-305.08M-$-140.24M-$-134.43M$45.4M-$-1.19B
Common stock issued$25.3M$1.05B$0.00$0.00$12.8M
Common stock repurchased-$-43.17M-$-650K-$-650K$0.00-$-420K
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-157.87M$164.7M-$-76.91M-$-73.81M$705.2M
Net change in cash$27.2M$48.2M-$-560K-$-33.11M-$-215.27M
Cash at end of period$88.5M$61.3M$13.1M$13.6M$46.7M
Operating cash flow$490.2M$23.8M$210.8M-$-4.65M$270.2M
Capital expenditure-$-95.48M-$-80.91M-$-73.53M-$-70.11M-$-59.27M
Free cash flow$394.7M-$-57.14M$137.3M-$-74.77M$210.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About BrightSpring Health Services, Inc. Common Stock

        BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.

        CEO
        Jon Rousseau
        Employees
        23.5K
        Beta
        1.79

        Explore

        Frequently asked questions

        What is the intrinsic value of BrightSpring Health Services, Inc. Common Stock (BTSG)?

        BrightSpring Health Services, Inc. Common Stock (BTSG) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is BTSG undervalued?

        BTSG trades at a price of $62.89 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.